ADM to Present Extended Health and Wellness Offering at CPhI 2018

Article

At this year’s CPhI Worldwide congress in Madrid, Spain, Archer Daniels Midland Company (ADM) will present its range of products spanning probiotics and microbiome solutions to highly purified, injectable-grade vegetable oils.

At this year’s CPhI Worldwide congress in Madrid, Spain, Archer Daniels Midland Company (ADM) will present its range of products spanning probiotics and microbiome solutions to highly purified, injectable-grade vegetable oils.

Visitors to booth 8C122 will be able to view the company's bioactive portfolio as well as the pharmaceutical-grade purified vegetables oils for use as APIs and excipients in injectable, oral, or topical formulations from ADM SIO. Innovative concepts to be showcased during the event include probiotic sticks and probiotic capsules. 

Additionally, there will be research data assessing the potential of these probiotics in the treatment and prevention of atopic dermatitis and mild to moderate psoriasis-as well as for use in weight management-accessible at the booth and may be discussed further with ADM Biopolis staff.

“Our world-class R&D team continues to explore future applications for our microbial technologies in line with increased demand for innovation and personalized nutrition solutions,” explained Daniel Ramon Calvo, marketing and communications manager, ADM Biopolis, in a press release. “Now as ADM, we have expertise across all stages of product development. This in-depth knowledge means we can support both pharmaceutical and food supplement customers in creating the next generation microbiome and biotech-based products for better living. We are, for instance, specialists in microbial strain and bioprocess design and development through cell factories.”

“Excipients are used in all drug formulations and are essential for product manufacturing and performance. We take advantage of our purification and analytical expertise to offer highly purified oils from vegetable origins, produced in our cGMP workshops, and compliant with the latest requirements from the main health authorities,” added Hervé Sibillat, general manager, ADM SIO, in the same press release.

Source: ADM

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content